SINGAPORE (Apr 3): Clearbridge Health is acquiring a 89.6% stake in IGM Labs of Indonesia for $9.4 million or 2.8 times its EV/EBITDA.

See also: Clearbridge Health started at ‘buy’ with 28 cents target by Phillip on growth trajectory

The sale and purchase agreement was signed between Clearbridge’s wholly-owned subsidiary SAM Laboratory and seller PT Kreasi Putra Nusantara.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook